Although some of these markers have been proposed for informing the choice of biologic treatment in RA [5], identification of baseline predictors for patient response to anti-TNF therapy in RA that reproducibly manifest clinically relevant predictive value remains an unsolved problem [6, 7]. Here, TNF is linked to rheumatoid arthritis.